The "THE MOST DISHONEST & CORRUPT MEDIA AWARDS OF THE YEAR" will be presented at 5pm local time on Monday, Jan 8, Trump said in a tweet from his official account.
White House press secretary Sarah Huckabee Sanders did not "want to spoil anything" on Wednesday, but she elaborated slightly on President Donald Trump's "fake news media" awards scheduled for Monday at 5 p.m.
He added: " Subjects will cover dishonesty and bad reporting in various categories from the fake news media. "Stay tuned!" the president tweeted.
Trump has been at loggerheads with several USA mainstream media outlets, including the CNN, ABC News, The New York Times and the Washington Post among others. They are all bad.
The announcement from the president is not fake news.
Evidently, Fox News gets a mulligan from this particular competition. Trump had tweeted on November 27.
Late in the evening, Fox News listed out some news stories of other networks that later bear out to be erroneous. "2018 will be a great year for America!" he wrote Sunday.
President Trump has been engaged in a head-on dispute with a number of United States conventional media channels, together with the CNN, ABC News, The New York Times and the Washington Post among others.
"Theres no point in pretending that some journalists are anything more than peddlers of falsehoods and liberal propaganda", it said.
Regardless of party, however, most Americans see fake news as a problem.
CNN's reported that Donald Jr. received an email on September 4, 2016 from WikiLeaks granting them special access to materials that would later become public - however, he received the email from WikiLeaks on the September 14, 2016 - after the documents had been published, which indicated there was not a collaboration with the hacker organization and Trump.
In 2017 he continued to publicly show his disdain for everyone from the BBC and the "failing" The New York Times, to CBS News, Vanity Fair and Anna Wintour, TIME magazine and Newsweek, to CNN, CNN International (DStv 401), The Washington Post, NBC News and MSNBC (StarSat 263).
Expensive gene therapy can cure the rarest blindness
That idea would apply to government programs like Medicare and Medicaid, which provide health coverage to the poor and elderly. Given Luxturna's federal approval and strong study results, experts say US insurers will likely cover the drug.